Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Week Multi-Centre, Randomized, Double-Blind, Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients

NCT00130455 is registered in ClinicalTrials.gov with Psychiatric Hospital, Hillerod as lead sponsor.

NCT NCT00130455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Week Multi-Centre, Randomized, Double-Blind, Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients
Lead sponsor
Psychiatric Hospital, Hillerod
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2006
Completion date
January 31, 2008
Enrollment
189
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression